Goldman Sachs Focused Value Fund Class A
GFVAX
NASDAQ
| Weiss Ratings | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Goldman Sachs | |||
| Manager/Tenure (Years) | Charles (Brook) Dane (6), Kevin Martens (5) | |||
| Website | http://https://am.gs.com | |||
| Fund Information | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Goldman Sachs Focused Value Fund Class A | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth | |||
| Inception Date | Jul 31, 2015 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.03% | |||
| Dividend | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.21% | |||
| Asset Allocation | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.58% | |||
| Stock | 97.42% | |||
| U.S. Stock | 97.42% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.39% | |||
| 30-Day Total Return | 3.67% | |||
| 60-Day Total Return | 5.61% | |||
| 90-Day Total Return | 9.19% | |||
| Year to Date Total Return | 2.93% | |||
| 1-Year Total Return | 13.60% | |||
| 2-Year Total Return | 30.69% | |||
| 3-Year Total Return | 51.94% | |||
| 5-Year Total Return | 103.45% | |||
| Price | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $15.79 | |||
| 1-Month Low NAV | $15.20 | |||
| 1-Month High NAV | $15.79 | |||
| 52-Week Low NAV | $13.37 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $17.57 | |||
| 52-Week High Price (Date) | Nov 26, 2024 | |||
| Beta / Standard Deviation | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.89 | |||
| Standard Deviation | 15.48 | |||
| Balance Sheet | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 60.20M | |||
| Operating Ratios | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.01% | |||
| Turnover Ratio | 85.00% | |||
| Performance | GFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 16.84% | |||
| Last Bear Market Total Return | -13.62% | |||